Research on Endocannabinoid System in PTSD and Substance Use
This article reviews endocannabinoid system PTSD substance use research focusing on trauma-focused treatments. Evidence shows these treatments remain effective despite cannabis use. Clinicians should consider this when planning PTSD care.
Cannabinoid Clinical Trials: Cannabis in Student Mental Health
This randomized controlled trial evaluates a digital mental health intervention students can access during the critical university transition. The study focuses on cannabis and other substance use alongside mental health outcomes. Results highlight the…
Clinical Research on Mental Health in Retired Athletes
Mental health retired athletes face elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Clinical research highlights factors like career-ending injuries and repeated head trauma as key influences. Early…
Ontario Labour Arbitration Highlights Cannabis Impairment Challenges
An Ontario labour arbitration decision highlights cannabis impairment workplace challenges. The ruling shows proving cannabis impairment is key in safety-sensitive roles. This case underscores the difficulty of detecting functional impairment versus mere…
Pres. Trump’s Executive Mandate Speeds DEA Licensing for Cannabis Research
DEA licensing cannabis research is accelerating due to recent executive actions. This change addresses longstanding regulatory delays that have hindered clinical investigation. The streamlined approval process is expected to expand research on cannabis…
Dabney: The Limits of Cannabis Impairment Testing
Cannabis impairment testing limitations are critical for clinicians to understand. Current breathalyzers and saliva tests detect cannabinoids but cannot reliably prove impairment. This gap affects patient counseling and legal interpretations.
Omagh Biotech Start-Up Boosts Research into Obesity and Epilepsy
Sonas Pharma’s funding boost advances endocannabinoid system obesity epilepsy research. This biotech aims to develop targeted therapeutics for these challenging conditions. The focus on endocannabinoid system obesity epilepsy offers hope for improved…
Cannabis and Cognitive Aging: New Insights for 2026
This digest reviews recent findings on cannabis and cognitive aging, highlighting reassuring safety data for older adults. It also addresses adolescent cannabis exposure risks and ongoing policy reform challenges. The focus on cannabis and cognitive…
West Virginia House Approves Medical Cannabis Edibles Bill
West Virginia medical cannabis program expands to include edible formulations, offering patients improved access and treatment options. Edibles provide pharmacokinetic advantages for those with respiratory issues or needing longer symptom relief. This…
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
The CBD endometriosis trial backed by the NHS is entering its dosing phase, offering hope for better pain management. This trial focuses on cannabidiol's role in treating chronic pelvic pain associated with endometriosis. Access to clinical trial data…